India at cusp of turnaround in fortunes, says RBI governor: Key points
Top Searches
India at cusp of turnaround in fortunes, says RBI governor: Key points
TIMESOFINDIA.COM / Updated: Feb 25, 2021, 13:11 IST
FacebookTwitterLinkedinEMail
NEW DELHI: Reserve Bank of India governor Shaktikanta Das on Thursday said that India is at the cusp of turnaround in fortunes with sectors recovering from Covid-induced slowdowns.
Addressing the 185th foundation day of Bombay Chamber of Commerce, Das noted that manufacturing sector has shown good recovery and is spearheading growth.
Highlighting that India now supplies more than half of the global demand for vaccines, the RBI governor emphasised that corporate sector needs to invest more in healthcare to create skill and scale.
Shaktikanta Das said that the recent spike in COVID-19 cases in some parts of the country needs to be contained and that it is important to remain vigilant and steadfast going ahead.
Expressing confidence in forming a NDA government in the Union Territory after the Assembly polls, the Prime Minister said, “Such a government will be people’s government and the high command will be people. I want to see the UT the BEST (business, education, spiritual, and tourism hub).”
A Bench of Justices L Nageswara Rao and Indira Banerjee made the observation while upholding an order of Jharkhand High Court which allowed appointment of 43 persons for post of Police Sub-Inspectors on the basis of their merit after authorities prepared a revised select list correcting the irregularities.
The lives of people lost due to wildlife-human conflicts are not adequately compensated in India, according to a new study which says changing the approach to this estimate can improve conservation efforts, and help understand which species to prioritise at conflict-prone zones.
RBI Governor Shaktikanta Das recently expressed concern regarding cryptocurrency trade. He said that crypto trade can have an adverse impact on financial stability. Is his concern justified? Here is all you need to know:
Loading the player.
Johnson & Johnson s single-dose COVID-19 vaccine effective, safe: FDA
Drug maker Johnson & Johnson s single-shot COVID-19 vaccine is safe and effective as per the data submitted from its ongoing multi-national Phase 3 randomised, double-blind and placebo-controlled trials. This is what a briefing document published by the US Food and Drug Administration (FDA) has said. Johnson & Johnson had sought emergency use authorisation for its vaccine on February 4. FDA s advisory committee for approving the vaccine will meet on Friday to take a decision on the issue.
RBI Governor Shaktikanta Das raises major concerns about cryptocurrency
Amid recent surge in demand for cryptocurrencies, the Reserve Bank of India has raised concerns that the digital currency may impact financial stability in India. All major concerns related to cryptocurrencies, such as regulations, have been conveyed to the government, RBI Governor Shaktikanta Das said on Wednesday. The central gov